The potential benefits of concomitant statins treatment in patients with non‐muscle‐invasive bladder cancer
BJU International · 2025
DOI: 10.1111/bju.16493 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, 2025. Verfasst von Kang Liu und 19 weiteren Autor:innen. Beteiligte Einrichtung: S.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Hydroxymethylglutaryl-CoA Reductase Inhibitors, BCG Vaccine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: University Grants Committee (UGC) Research Matching Fund, General Research Fund/Early Career Scheme of the Research Grants Council, Hong Kong.
Abstract (Originalsprache)
Objective
To investigate the influence of statins on the survival outcomes of patients with non‐muscle‐invasive bladder cancer (NMIBC) treated with adjuvant intravesical bacille Calmette‐Guérin (BCG) immunotherapy. Patients and Methods A retrospective cohort of consecutive patients with NMIBC who received intravesical BCG therapy from 2001 to 2020 and statins prescription were identified. Overall survival (OS), cancer‐specific survival (CSS), recurrence‐free survival (RFS), and progression‐free survival (PFS) were analysed between the Statins Group vs No‐Statins Group using Kaplan–Meier method and multivariable Cox regression.
Results
A total of 2602 patients with NMIBC who received intravesical BCG were identified. The median follow‐up was 11.0 years. On Kaplan–Meier analysis, the Statins Group had significant better OS ( P < 0.001), CSS ( P < 0.001), and PFS ( P < 0.001). Subgroup analysis indicated statins treatment started before BCG treatment had better CSS ( P = 0.02) and PFS ( P < 0.01). Upon multivariable Cox regression analysis, the ‘statins before BCG’ group was an independent protective factor for OS (hazard ratio [HR] 0.607, 95% confidence interval [CI] 0.514–0.716), and CSS (HR 0.571, 95% CI 0.376–0.868), but not RFS (HR 0.885, 95% CI 0.736–1.065), and PFS (HR 0.689, 95% CI 0.469–1.013).
Conclusions
Statins treatment appears to offer protective effects on OS and CSS for patients with NMIBC receiving adjuvant intravesical BCG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- S.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
- Department of Experimental and Clinical Biomedical Science, University of Florence, Florence, Italy.
- Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
- Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
- Department of Urology, Medical University of Vienna, Vienna, Austria.
- Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
ORCID-Profile: Kang Liu, Hongda Zhao, Peter Ka-Fung Chiu, Renate Pichler, Takafumi Yanagisawa, Luca Afferi, Andrea Mari, Satoshi Katayama, Juan Gomez Rivas, Riccardo Campi, Maria Carmen Mir, Yair Lotan, Jeremy Yuen-Chun Teoh
Förderung
- University Grants Committee (UGC) Research Matching Fund
- General Research Fund/Early Career Scheme of the Research Grants Council, Hong Kong
Zitieren
APA
Liu, K., Nicoletti, R., Zhao, H., Chen, X., Chiu, P. K., Ng, C. F., Pichler, R., Mertens, L. S., Yanagisawa, T., Afferi, L., Mari, A., Katayama, S., Rivas, J. G., Campi, R., Mir, M. C., Rink, M., Lotan, Y., Rouprêt, M., Shariat, S. F., & Teoh, J. Y. (2025). The potential benefits of concomitant statins treatment in patients with non‐muscle‐invasive bladder cancer. BJU International. https://doi.org/10.1111/bju.16493
Vancouver
Liu K, Nicoletti R, Zhao H, Chen X, Chiu PK, Ng CF, et al. The potential benefits of concomitant statins treatment in patients with non‐muscle‐invasive bladder cancer. BJU International. 2025. doi:10.1111/bju.16493
BibTeX
@article{Liu2025,
author = {Liu, Kang and Nicoletti, Rossella and Zhao, Hongda and Chen, Xuan and Chiu, Peter Ka-Fung and Ng, Chi-Fai and Pichler, Renate and Mertens, Laura S and Yanagisawa, Takafumi and Afferi, Luca and Mari, Andrea and Katayama, Satoshi and Rivas, Juan Gomez and Campi, Riccardo and Mir, Maria Carmen and Rink, Michael and Lotan, Yair and Rouprêt, Morgan and Shariat, Shahrokh F and Teoh, Jeremy Yuen-Chun},
title = {The potential benefits of concomitant statins treatment in patients with non‐muscle‐invasive bladder cancer},
journal = {BJU International},
year = {2025},
doi = {10.1111/bju.16493}
}
EUVIMED